These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 12595973

  • 1. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?
    De Carlis L, Giacomoni A, Lauterio A, Slim A, Sammartino C, Pirotta V, Colella G, Forti D.
    Transpl Int; 2003 Feb; 16(2):115-22. PubMed ID: 12595973
    [Abstract] [Full Text] [Related]

  • 2. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation.
    De Carlis L, Giacomoni A, Pirotta V, Lauterio A, Slim AO, Sammartino C, Cardillo M, Forti D.
    J Am Coll Surg; 2003 Jun; 196(6):887-97. PubMed ID: 12788425
    [Abstract] [Full Text] [Related]

  • 3. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 4. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
    Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR, Nery JR, Burke GW, Schiff ER, Miller J, Tzakis AG.
    Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
    [Abstract] [Full Text] [Related]

  • 5. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.
    Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
    [Abstract] [Full Text] [Related]

  • 6. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM.
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [Abstract] [Full Text] [Related]

  • 7. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.
    Figueras J, Ibañez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, Mir J, Loinaz C, Herrera L, López-Cillero P, Santoyo J.
    Liver Transpl; 2001 Oct; 7(10):877-83. PubMed ID: 11679986
    [Abstract] [Full Text] [Related]

  • 8. Liver transplantation for malignant diseases: selection and pattern of recurrence.
    Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I.
    World J Surg; 2002 Feb; 26(2):257-63. PubMed ID: 11865357
    [Abstract] [Full Text] [Related]

  • 9. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
    Del Gaudio M, Grazi GL, Principe A, Ravaioli M, Ercolani G, Cescon M, Varotti G, Gardini A, Cavallari A.
    Hepatogastroenterology; 2004 Feb; 51(56):510-4. PubMed ID: 15086193
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL, Zang YJ, Chen XG, Shen ZY.
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [Abstract] [Full Text] [Related]

  • 11. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
    Zhou J, Fan J, Wu ZQ, Qiu SJ, Huang XW, Yu Y, Wang Z, Sun J, Xiao YS, He YF, Yang GH, Song K, Yuan Z, Wang YQ, Tang ZY.
    Chin Med J (Engl); 2005 Apr 20; 118(8):654-9. PubMed ID: 15899120
    [Abstract] [Full Text] [Related]

  • 12. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F, Angele MK, Rentsch M, Graeb C, Gerbes A, Löhrs U, Beuers U, Jauch KW.
    Clin Transplant; 2007 Apr 20; 21(6):696-701. PubMed ID: 17988261
    [Abstract] [Full Text] [Related]

  • 13. HCC in living donor liver transplantation: can we expand the Milan criteria?
    Kwon CH, Kim DJ, Han YS, Park JB, Choi GS, Kim SJ, Joh JW, Lee SK.
    Dig Dis; 2007 Apr 20; 25(4):313-9. PubMed ID: 17960066
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors for hepatocellular carcinoma recurrence: experience with 83 liver transplantation patients.
    Ataide EC, Boin IF, Almeida JR, Sevá-Pereira T, Stucchi RS, Cardoso AR, Caruy CA, Escanhoela CA.
    Transplant Proc; 2011 May 20; 43(4):1362-4. PubMed ID: 21620130
    [Abstract] [Full Text] [Related]

  • 15. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
    Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, Shimada M, Maehara Y.
    Transplantation; 2007 Apr 15; 83(7):893-9. PubMed ID: 17460559
    [Abstract] [Full Text] [Related]

  • 16. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
    Vivarelli M, Cucchetti A, Piscaglia F, La Barba G, Bolondi L, Cavallari A, Pinna AD.
    Liver Transpl; 2005 May 15; 11(5):497-503. PubMed ID: 15838913
    [Abstract] [Full Text] [Related]

  • 17. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun 15; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

  • 18. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT.
    Liver Transpl; 2004 Nov 15; 10(11):1343-54. PubMed ID: 15497158
    [Abstract] [Full Text] [Related]

  • 19. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
    Marubashi S, Dono K, Nagano H, Sugita Y, Asaoka T, Hama N, Miyamoto A, Takeda Y, Umeshita K, Monden M.
    Transpl Int; 2007 Jul 15; 20(7):576-82. PubMed ID: 17425725
    [Abstract] [Full Text] [Related]

  • 20. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK.
    Liver Transpl; 2007 Apr 15; 13(4):543-51. PubMed ID: 17394152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.